Home
>
National Drug Code (NDC)
>
Etomidate
Etomidate - 40042-025-20 - (Etomidate)
Drug Information of Etomidate
| Product NDC: | 40042-025 |
| Proprietary Name: | Etomidate |
| Non Proprietary Name: | Etomidate |
| Active Ingredient(s): | 2 mg/mL & nbsp; Etomidate |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Etomidate
| Product NDC: | 40042-025 |
| Labeler Name: | PharmaForce, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA078867 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20100608 |
Package Information of Etomidate
| Package NDC: | 40042-025-20 |
| Package Description: | 10 VIAL, GLASS in 1 CARTON (40042-025-20) > 20 mL in 1 VIAL, GLASS |
NDC Information of Etomidate
| NDC Code | 40042-025-20 |
| Proprietary Name | Etomidate |
| Package Description | 10 VIAL, GLASS in 1 CARTON (40042-025-20) > 20 mL in 1 VIAL, GLASS |
| Product NDC | 40042-025 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Etomidate |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20100608 |
| Marketing Category Name | ANDA |
| Labeler Name | PharmaForce, Inc. |
| Substance Name | ETOMIDATE |
| Strength Number | 2 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | General Anesthesia [PE],General Anesthetic [EPC] |
